Austin, TX – According to filings with the U.S. Securities and Exchange Commission, Entvantage Diagnostic Associates is raising $1,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Joseph Skraba played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About Entvantage Diagnostic Associates

ENTvantage Dx is an in-vitro diagnostics company that provides Primary Care Physicians and Otolaryngologists with rapid, in-office diagnostic tests to determine the cause of ear, nose and throat illnesses. Unnecessary antibiotics Can make patients worse or lead to antibiotic-resistant infections, together we can reduce the use of antibiotics for ear, nose and throat illnesses. ENTvantage Dx diagnostic tests accurately distinguish bacterial from viral infections, reducing unnecessary prescription of antibiotics.

To learn more about Entvantage Diagnostic Associates, visit http://www.entvantagedx.com/

Contact:
Joseph Skraba, Chief Executive Officer
512-431-6071
https://www.linkedin.com/in/joseph-skraba-537a73/

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved